Analysis Med Biogene, Inc. (MBGNF)
6/3/2024
Analysis of Med Biogene, Inc. (MBGNF)
Med Biogene, Inc. (MBGNF) has been showing consistent stability in its stock price, with the closing price remaining at $0.01 for the past several days. The Relative Strength Index (RSI) indicator is very high at 98.12, indicating that the stock may be overbought.Looking at the Moving Average Convergence Divergence (MACD) indicator, we see that the MACD line is close to the signal line, with a small negative histogram. This suggests a possible weakening of the bullish momentum.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all around $0.01, indicating a stable trend.
Overall, while the stock price of Med Biogene, Inc. has remained stable, the high RSI and the weakening MACD signal suggest a potential reversal or correction in the near future. Investors should closely monitor these indicators for any changes in the stock's momentum.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a generally positive outlook for the company, with expected growth in both quarterly and annual sales over the coming periods.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight decrease in growth rate from the past 5 years to the next 5 years. However, the company is still expected to maintain a healthy growth rate in the upcoming periods.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $201.43 and an average forecast of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security is $192.25, which is below both the median and average forecasted prices.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company's book value per share is $4.837, total cash per share is $4.379, and total debt to equity ratio is 140.968.In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The most recent quarter ended on March 31, 2024, and the fiscal year ends on September 30, 2023.
From the income statement, we see that the company generated $381.62 billion in revenue, with a gross profit of $169.15 billion and a net income to common of $100.39 billion. The EBITDA is $131.39 billion and the diluted EPS is $6.43. The company experienced a quarterly revenue growth of -4.3% and a quarterly earnings growth year-over-year of -2.2%.
In terms of stock statistics, the company has a short ratio of 1.53 and a short percent of shares outstanding of 0.65%. The float shares are 15.31 billion, with 99.29 million shares being shorted. The company's market capitalization is $2.92 trillion.
The valuations metrics show a PEG ratio of 26.32, a forward PE ratio of 26.32, and a trailing PE ratio of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and a price to sales ratio of 7.65. The enterprise to EBITDA ratio is 22.76 and the enterprise to revenue ratio is 7.73.
In terms of stock price summary, the company has a beta of 1.26 and a 52-week low of $164.08 and a high of $199.62. The 52-week change is 6.85%.
Lastly, in dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%. The dividend date is May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, the gross profit has generally followed the trend of increasing sales revenue.
3. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
4. Net income has also shown an increasing trend, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. The company has been able to manage its operating expenses effectively, as seen in the consistent growth of operating income.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to generate positive non-operating interest income, contributing to its overall profitability.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company seems to be investing more in non-current assets over the years, which is reflected in the increase in total assets.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2021.
5. Financing activities show significant changes each year, with common stock repurchases and debt issuances impacting the cash flow.
6. Investing activities also vary, with the company engaging in acquisitions, investments, and capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in cash flow driven by financing and investing activities.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth from the EPS of $5.67 in the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This is an increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts are forecasting growth in earnings per share for both the upcoming quarters and the full fiscal years, indicating positive expectations for the company's performance.
MACD of MBGNF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
